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ABSTRACT A better understanding of the molecular mechanisms of signaling by the 
neurotransmitter serotonin is required to assess the hypothesis that defects in serotonin signaling 
underlie depression in humans. Caenorhabditis elegans uses serotonin as a neurotransmitter to 
regulate locomotion, providing a genetic system to analyze serotonin signaling. From large-scale 
genetic screens we identified 36 mutants of C. elegans in which serotonin fails to have its normal 
effect of slowing locomotion, and we molecularly identified eight genes affected by 19 of the 
mutations. Two of the genes encode the serotonin-gated ion channel MOD-1 and the G protein 
coupled serotonin receptor SER-4. mod-1 is expressed in the  neurons and muscles that directly 
control locomotion, while ser-4 is expressed in an almost entirely non-overlapping set of sensory 
and interneurons. The cells expressing the two receptors are largely not direct postsynaptic 
targets of serotonergic neurons. We analyzed animals lacking or overexpressing the receptors in 
various combinations using several assays for serotonin response. We found that the two 
receptors act in parallel to affect locomotion. Our results show that serotonin functions as an 
extrasynaptic signal that independently activates multiple receptors at a distance from its release 
sites and identify at least six additional proteins that appear to act with serotonin receptors to 
mediate serotonin response. 
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Depression is hypothesized to involve dysfunction of the neurotransmitter serotonin (Cowen, 
2008). Understanding the molecular mechanism of serotonin signaling is complicated by the fact 
that the human brain expresses 14 types of serotonin receptors, one of which is a serotonin-gated 
ion channel, and the rest of which are G protein coupled receptors (Millan et al. 2008). An 
additional challenge to understanding serotonin signaling is the fact that serotonin can act locally 
at synapses where it is released, or diffuse away and act at distant receptors. While classical 
neurotransmitters such as GABA and glutamate appear to function mainly locally at synapses, 
serotonin can diffuse several microns from its release sites at concentrations sufficient to activate 
its receptors (Bunin and Wightman, 1998). Further, serotonin receptors are often localized at 
non-synaptic sites (Kia et al. 1996). These observations suggest that serotonin might act 
predominantly as an extrasynaptic signal to activate several receptor types on cells distant from 
its release sites and that the combined action of these several receptors somehow coordinates 
appropriate responses to serotonin. The details of how such action might occur remain unclear. 
 C. elegans uses serotonin as a neurotransmitter (Horvitz et al. 1982; Chase and Koelle, 
2005) and provides a model system with the potential to make important contributions to the 
study of serotonin signaling. First, C. elegans allows the use of forward genetic screens to 
identify the proteins beyond serotonin receptors that mediate serotonin response. Second, the 
known synaptic wiring of the C. elegans nervous system (White et al. 1986) provides the 
opportunity to directly test whether serotonin acts at synapses or extrasynaptically. 
 Previous studies of C. elegans have shown that of the precisely 302 neurons found in an 
adult hermaphrodite, the NSM, HSN, ADF, VC4/5, AIM, and RIH neurons contain serotonin, 
although the AIM, RIH, and possibly also the VC4/5 neurons do not synthesize serotonin 
themselves but rather take up serotonin made by the other neurons (Horvitz et al. 1982; Sawin et 
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al. 2000; Jafari at al. 2011). Animals with mutations in the enzymes that synthesize serotonin or 
in which the NSMs have been ablated are defective for the strong reduction in locomotion 
behavior, known as enhanced slowing, that occurs when food-deprived animals encounter food 
(Sawin et al. 2000). This observation suggests that the NSMs release serotonin to slow 
locomotion. While enhanced slowing is only one of several behaviors known to be controlled by 
serotonin in C. elegans (Chase and Koelle 2007), it is amenable to genetic analysis, and direct 
genetic screens for mutants defective in enhanced slowing behavior have succeeded in isolating 
mutants defective for serotonin signaling (Sawin et al. 2000). However, assays for this behavior 
are relatively tedious. In a second approach, mutants carrying gene knockouts for all five C. 
elegans serotonin receptor homologs have been tested for defects in the ability of serotonin to 
slow locomotion (Hapiak et al. 2009). Several of the receptor knockouts cause defects in this 
behavior, but basic issues about the functions of these receptors have remained unresolved. How 
do the receptors act together to slow locomotion? Do they act at sites distant from serotonin 
release sites? Do the various receptors act in the same or different cells? What other signaling 
proteins act with the receptors to mediate serotonin response? 
 In this study we developed genetic screens for C. elegans mutants defective for the 
effects of serotonin on locomotion. We identified 36 mutants, found the relevant molecular 
lesions in 19 of them, and thus identified eight proteins required for serotonin response. Among 
these proteins were two serotonin receptors, MOD-1 and SER-4. Since understanding how the 
remaining signaling proteins affect serotonin response first requires understanding the function 
of the two receptors, we analyzed how MOD-1 and SER-4 affect locomotion. Our results suggest 
the two receptors act in parallel in different cells to mediate different effects of extrasynaptic 
serotonin on locomotion. 
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Materials and Methods 
Nematode Culture 
C. elegans strains were maintained at 20° under standard conditions, and double- and triple-
mutant strains were generated using standard genetic techniques (Brenner 1974). All strains and 
transgenes used in this study are described in the Supporting Information.  
 
Genetic Screens 
 In a clonal screening strategy, fourth-stage larval (L4) wild-type hermaphrodites were 
mutagenized (Brenner 1974) using ethyl methanesulfonate (EMS), and F1 progeny were grown 
from eggs harvested after bleaching the P0 gravid adults. First larval-stage F1 animals were 
diluted to one per 100 µl in S medium (Sulston and Hodgkin 1988) supplemented with penicillin 
and streptomycin (Gibco 15140-122, final concentrations 100 units/ml and 100 µg/ml, 
respectively), nysatin (Sigma N1638, final concentration 100 units/ml), and E. coli strain HB101 
diluted to a final OD550=2.4. A 12-channel pipette was used to distribute 50 µl/well into 96-well 
plates. Wells containing >1 F1 were marked and not screened. Plates were placed in a plastic 
container with a loose-fitting lid containing wet paper towels and incubated for 6 days at 20° 
until mixed-stage F2 progeny were present but the cultures were not yet starved. 100 µl of 45 
mM serotonin (5-hydroxytryptamine creatine sulfate complex, Sigma H-7752) was added to each 
well. The supersaturated 45 mM serotonin stock solution was prepared by adding serotonin 
powder to S medium lacking trace metals, heating in a water bath to 80° for 5 minutes, 
vortexing, cooling to room temperature, and using within 30 minutes. 
For non-clonal genetic screens, mod-5(n3314) L4 hermaphrodites were mutagenized 
using EMS or the Mosl transposon (Boulin and Bessereau 2007). Five P0 animals were 
transferred to each of several 10 cm diameter NGM plates (Brenner 1974) and allowed to 
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produce F1 progeny for 3-5 days at 20°. F1 progeny were bleached to collect eggs. 
Approximately 300 eggs from each 10 cm plate were spotted to 6 cm diameter NGM plates and 
grown at 20° for two days. These F2 progeny were transferred to 24-well cell culture plates 
containing 20 mM or 60 mM serotonin dissolved in M9 buffer (Sulston and Hodgkin 1988) and 
assayed for movement five minutes later. Moving animals were transferred from wells using a 
mouth pipette to individual 6 cm NGM plates, and their progeny were retested for serotonin 
resistance. 
 
Measurement of the serotonin-resistance phenotype in liquid 
Serotonin resistance measurements in Table 1 and Figure 2A were performed in M9 buffer in 
microtiter wells containing serotonin. Serotonin was prepared as a 45 mM stock solution in M9 
by heating to 80°, vortexing, and cooling as described above. Animals were isolated at the late 
L4 stage based on the morphology of the developing vulva and cultured for 24 hrs at 20° to 
produce young adults. Animals were transferred with a platinum wire worm pick to microtiter 
wells containing 50 µl M9 buffer, typically 25-33 animals per well. A 12-channel pipette was 
used to add serotonin stock solution to the final desired concentration, and 20 min later wells 
were scored for the number of animals “moving,” defined as having smooth swimming 
movements of the entire body. Animals showing only movements of the head or only stiff or 
jerky movements of ≤50% of the body were scored as not “moving.” 
 Serotonin resistance measurements shown in Figure 2B and 2C were performed in an 
analogous fashion, except that the young adult animals were picked directly into microtiter wells 
containing various concentrations of serotonin dissolved in water and were scored for movement 
20 min later. We found that about 30-fold less serotonin is sufficient to paralyze C .elegans when 
   8 
it is applied in water rather than in M9 buffer, analogous to the similarly large increase in 
effectiveness of exogenous dopamine on C. elegans when it is applied in water rather than M9 
buffer (Schafer and Kenyon, 1995). We thus performed quantitative assays of response to 
serotonin in water or on agar dissolved in pure water (see below) so that serotonin could be used 
to affect behavior at concentrations below its solubility limit, producing more reliable assays. 
 
Measurement of serotonin resistance after optogenetic activation of endogenous serotonin 
release 
B broth inoculated with OP50 bacteria (Sulston and Hodgkin 1988) was cultured overnight at 
37° without shaking, and just before use 4 µl of 100 mM all-trans retinal (Spectrum Chemical 
Mfg. Corp., #R3041) in 100% ethanol was added per 1 ml. Standard NGM plates were seeded 
with 200 µl of this mix. Plates were incubated in a light-tight box overnight at room temperature 
to allow a bacterial lawn to grow. Control plates were made with no trans-retinal. 24 hours 
before the assay late L4 animals were picked onto freshly prepared retinal or control plates and 
incubated at 20° overnight in the dark. 30 min prior to assay, unseeded NGM assay plates were 
ringed with an osmotic barrier to prevent worms from leaving the agar surface by placing a 70 µl 
drop of 4M fructose on the edge of each plate and tilting the plate around in a circle. For the 
assay, individual worms not on the OP50 lawn were picked to separate fructose-ringed NGM 
plates using a bare pick. 10 minutes after transfer, each plate was moved to a Zeiss M2BIO 
fluorescence dissecting scope, handling the plates gently and leaving the lids in place to avoid 
mechanically stimulating the animals. Animals were illuminated with 1.2 mW/mm2 of 480 nm 
light, as measured with a Solar Meter model 9.4 blue light radiometer (Solartech Inc.). The 
number of body bends was counted during the first 30 seconds of blue light exposure. A body 
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bend was defined as a maximum flexure of the body just behind the pharynx in the opposite 
direction as the previously-scored bend. ≥15 animals per condition were tested with the 
experimenter blinded to the genotype, and the experiment was repeated three times. Figure 4 
shows results from one representative experiment. 
 
Locomotion slowing assays 
Slowing assays were performed as described by Sawin et al. (2000).  Measurements shown are 
averaged from assays repeated over 2-9 days with samples totaling at least 20 animals for the no 
food assays and at least 40 animals for the + food assays. 
 
Gene Identification 
 Serotonin resistance mutations were mapped to regions of individual chromosomes using 
a combination of conventional marker mutations and single nucleotide polymorphisms (Fay 
2006). For mutations that mapped to regions including genes known to mutate to the serotonin-
resistant phenotype (goa-1, eat-16, ser-4, mod-1, and flp-1), we performed complementation 
tests with mutations in these genes and also amplified the candidate genes from the mutant 
strains and used DNA sequencing to identify mutant lesions. The mutation emb-9(vs114), in 
addition to causing weak serotonin resistance, caused a temperature-sensitive lethal phenotype 
that facilitated mapping and complementation tests. elpc-3(vs119) was mapped to a ~40 kb 
interval using single nucleotide polymorphisms, and all genes within that interval were amplified 
and then sequences determined from the mutant strain to identify the elpc-3 lesion. For the three 
Mos1 transposon insertion alleles, we used inverse PCR amplification of genomic DNA flanking 
the insert and DNA sequencing to determine that the insertions were in goa-1, mod-1, and abts-1. 
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Fluorescence microscopy 
C. elegans was immobilized with 10 mM levamisole, and a Zeiss LSM 710 confocal microscope 
was used to obtain Z-stack images. The 3D reconstructions seen in Figure 3, Figure S1, and File 
S3 were created using Volocity software (Improvision). 
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Results 
Genetic screens for mutants with defects in response to exogenous serotonin 
When C. elegans is placed in liquid medium it continuously flexes its body (File S1), and we 
found that addition of serotonin reduces these movements in a dose-dependent manner such that 
high concentrations eliminate almost all body bends except for small movements of the head 
(File S2). 
 We performed several genetic screens for serotonin-resistant mutants that continue to 
move at high doses of exogenous serotonin. In one “clonal” strategy, schematized in Figure 1, 
individual F1 progeny of mutagenized animals were cultured for one generation in separate 
microtiter wells so that each well contained a brood of F2 animals sharing the same mutations. 
Serotonin (30 mM) was added to the cultures, and wells containing >20% serotonin-resistant 
animals were identified. We thus screened 6,000 wells, representing 12,000 mutagenized haploid 
genomes, and identified 12 serotonin-resistant mutants.  
 We performed additional screens in which F1 progeny were cultured in groups rather than 
individually, and their F2 progeny were screened en masse for individuals that were not 
paralyzed by 20 or 60 mM serotonin. This “non-clonal” strategy allowed animals representing 
many more mutagenized genomes to be screened but was complicated by the fact that since even 
high concentrations of serotonin do not paralyze 100% of wild-type animals, a large number of 
false positives might be initially isolated that would then have to be discarded during subsequent 
retesting. To minimize this problem, the non-clonal screens were performed using a strain 
mutant for the serotonin reuptake transporter (SERT) MOD-5 (Ranganathan et al. 2001). SERT 
acts to terminate serotonin signaling by removing serotonin from the extracellular space, so a 
SERT-defective mutant has elevated serotonin signaling. We found that serotonin at 
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concentrations above 20 mM can paralyze nearly 100% of mod-5 mutant animals. The non-
clonal screens used either a chemical mutagen (a total 42,000 mutagenized haploid genomes 
from screens performed at 20 or 60 mM serotonin) or Mos1 transposon mutagenesis (63,000 
mutagenized haploid genomes screened at 60 mM serotonin). We thus isolated 24 more mutants. 
Table 1 lists details of all 36 serotonin-resistant mutants identified. 
 
Serotonin-resistance mutations identify eight proteins, including two serotonin receptors, 
that affect response to exogenous serotonin 
To identify the genes affected by the serotonin-resistance mutations, we performed a 
combination of genetic mapping, complementation tests, inverse PCR amplification in the case 
of transposon-insertion mutations, and PCR amplification of candidate genes followed by DNA 
sequence determination in the case of chemically-induced mutations. We thus mapped 30 of the 
36 mutations to specific chromosomes and subsequently identified the molecular lesions causing 
serotonin resistance in 19 of the mutants. In each case of a gene identified by a single mutation 
from our serotonin-resistance screens, we obtained a deletion or other independently-isolated 
mutation for that gene and verified that it induced a similar serotonin-resistance phenotype. 
 The 19 serotonin-resistance mutations identified eight different proteins required for 
serotonin response (Table 2). MOD-1 is a serotonin-gated chloride channel (Ranganathan et al. 
2000), while SER-4 is a G protein coupled serotonin receptor (Olde and McCombie 1997). 
GOA-1 is the C. elegans ortholog of the major neural G protein Gαo (Lochrie et al. 1991) and is 
a member of the Gαi/o class of G proteins thought to be activated by SER-4 (Olde and 
McCombie 1997). Serotonin-resistance of MOD-1, SER-4, and GOA-1 mutants has been noted 
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previously (Ségalat et al. 1995; Ranganathan et al. 2000; Hapiak et al. 2009) and suggests that 
serotonin acts directly on two different receptors to inhibit locomotion. 
 Five additional proteins that affect serotonin response were identified in our screens. 
EAT-16 is a G protein regulator known to function with GOA-1 (Hajdu-Cronin et al. 1999) and 
thus could affect SER-4/GOA-1 signaling. ABTS-1 is a transmembrane chloride transporter that 
controls the chloride gradient across the plasma membrane (Bellemer et al. 2011) and thus could 
affect the function of the serotonin-gated chloride channel MOD-1. We note, however, that we 
isolated an abts-1 mutant in a screen performed using the mod-5 mutant background, and we 
have not detected any effect of abts-1 mutations on serotonin response in a wild-type background 
(data not shown). FLP-1 is a neuropeptide previously known to affect serotonin response (Nelson 
et al. 1998), ELPC-3 is the catalytic subunit of a lysine acetylase protein complex (Chen et al. 
2009; Solinger et al. 2010), and EMB-9 is a collagen that is a component of basement 
membranes (Graham et al. 1997). 
 Our results suggest MOD-1 and SER-4 are serotonin receptors that inhibit C. elegans 
locomotion, and we propose that the other proteins detected in our genetic screens affect 
signaling by MOD-1 and/or SER-4. To lay the foundation for understanding how all of the 
proteins mediate serotonin response, we first focused on how the two receptors affect 
locomotion. 
 
SER-4 and MOD-1 act in parallel to mediate response to exogenous serotonin 
We quantitated the effects of ser-4 and mod-1 null mutations on the ability of exogenous 
serotonin to paralyze C. elegans. When assayed under conditions similar to those of our genetic 
screens, in M9 buffer, the receptor single mutants were strongly serotonin-resistant, with ~80% 
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of the mutant animals continuing to move at a serotonin concentration sufficient to paralyze all 
but 10% of the wild type (Figure 2A). While systematically varying the assay conditions, we 
found that the salts present in nematode growth media strongly inhibit serotonin response, so that 
about 30-fold less serotonin was sufficient to paralyze animals if the assay was performed in 
water instead. By assaying in water, we were for the first time able to observe responses of C. 
elegans to exogenous serotonin at concentrations of serotonin below its solubility limit, greatly 
improving the reliability our serotonin response assays. We generated serotonin dose-response 
curves by placing young adults into microtiter wells with various concentrations of serotonin in 
water and analyzed the ability of serotonin to paralyze mutants lacking the receptors individually 
or in combination. Wild-type animals were paralyzed in a dose-dependent fashion by serotonin 
in water (Figure 2B). In this assay condition, the ser-4 and mod-1 single null mutants showed 
only weak serotonin resistance, but the ser-4; mod-1 double mutant showed much stronger 
serotonin resistance. 
 In a second approach to understanding the functional relationship between the two 
receptors, we generated a strain carrying a chromosomally-integrated transgene with multiple 
copies of a mod-1 genomic clone and that presumably overexpresses MOD-1. We found that 
these mod-1(xs) animals were hypersensitive to paralysis by exogenous serotonin in water, in 
that mod-1(xs) animals were paralyzed by serotonin at a concentration about 30-fold lower than 
that required to paralyze the wild type (Figure 2C). The mod-1(xs) transgene also caused a 
baseline paralysis of ~25% of the animals in this assay even when no exogenous serotonin was 
added, possibly because of endogenous serotonin signaling through overexpressed MOD-1. 
When the mod-1(xs) transgene was combined with the ser-4(null) mutation, this baseline 
paralysis was suppressed, but the ser-4; mod-1(xs) strain still showed hypersensitivity to 
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exogenous serotonin similar to that of the mod-1(xs) strain, as the slopes of the dose/response 
curves for the two strains were similar. Thus MOD-1 can mediate the ability of exogenous 
serotonin to paralyze animals even in the absence of SER-4. 
 Our results indicate that SER-4 and MOD-1 are the principal receptors that mediate the 
ability of serotonin to slow locomotion, as they are the only serotonin receptors so far identified 
by our genetic screen, and at least in high-salt buffer, null mutants for either receptor lead to 
strong serotonin resistance. When assayed in water, the ser-4; mod-1 double null mutant can still 
be paralyzed by sufficiently high concentrations of exogenous serotonin, so additional 
receptor(s) must also mediate the ability of serotonin to slow of locomotion in this condition. 
SER-4 and MOD-1 appear to function in parallel to each other to mediate slowing of locomotion 
since null mutants for the individual receptors are not as serotonin resistant as is the ser-4; mod-1 
double mutant. 
 
mod-1 and ser-4 are expressed in almost completely non-overlapping sets of cells 
To further clarify the relationship between SER-4 and MOD-1, we examined the expression 
patterns of the mod-1 and ser-4 genes. Because the specific muscles, motor neurons, and 
interneurons that control C. elegans locomotion have been well-characterized (Von Stetina et al. 
2006), understanding precisely which of these cells express the receptors serves as a starting 
point for understanding how each receptor affects locomotion. Previous studies have generated 
transgenic animals that express the green fluorescent protein GFP from the mod-1 or ser-4 
promoters and have reported the identification of some cells that express each reporter 
(Ranganathan et al. 2000; Tsalik et al. 2003; Carnell et al. 2005; Harris et al. 2009).  However, 
these studies do not entirely agree, probably because of the weak and variable expression from 
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the extrachromosomal transgenes used. We used chromosomally-integrated mod-1:mCherry and 
ser-4::GFP transgenes that gave strong stable expression and allowed us to directly compare the 
expression of mod-1 and ser-4 reporters in the same animals. 
 We found that the mod-1 and ser-4 reporter transgenes were expressed in almost non-
overlapping sets of cells (Figure 3, A-F and File S3). In agreement with previous work 
(Ranganathan et al. 2000; Tsalik et al. 2003; Carnell et al. 2005; Harris et al. 2009), we found 
that mod-1 and ser-4 are each expressed in a subset of head and tail neurons. Using double-
transgenic animals, we found that there was only one type of cell that reliably coexpressed both 
reporter transgenes (Figure 3C and File S3). The coexpressing cells were a bilaterally-symmetric 
pair of head neurons previously identified as either RIB (Tsalik et al. 2003) or AIB (Harris et al. 
2009), two interneuron types that have very similar cell body positions and process morphology. 
Harris et al. (2009) reported that mod-1 functions in AIB, and our analysis of the cell body 
position of the double-labeled cell is also most consistent with AIB. RIB and AIB are among the 
many head interneurons that directly or indirectly synapse onto the command interneurons to 
control whether C. elegans moves forward or backward (White et al. 1986; Von Stetina et al. 
2006). We identified some cells that had not previously been reported to express mod-1 or ser-4 
reporters. Specifically, we saw mod-1::mCherry expression in RME neurons (Figure S1A) and 
ser-4::GFP expression in the serotonergic NSM neurons (Figure 3C) and in the vm2 egg-laying 
muscles (Figure S1B). 
The mod-1::mCherry reporter was expressed in muscles and neurons that directly control 
locomotion. By examining larvae at the L3 stage or younger we saw that the mod-1 reporter was 
expressed strongly in all body wall muscles, the cells that directly execute body bends during C. 
elegans locomotion (Figure 3G). We then found that in L4 larvae and adults this body wall 
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muscle expression was much reduced, but still detectable (Figure 3H). It was previously reported 
(Ranganathan et al. 2000) that a mod-1 reporter was expressed in unidentified cells of the ventral 
nerve cord, which contain motor neurons that synapse onto the body wall muscles. We also saw 
ventral cord neurons expressing mod-1::mCherry (Figure 3I). To identify these cells, we 
generated strains that carried the mod-1::mCherry transgene plus an unc-47::GFP transgene to 
label the GABAergic motor neurons (Figure 3J) or an unc-17::GFP transgene to label the 
cholinergic motor neurons (data not shown). MOD-1 expression overlapped perfectly in the 
ventral cord with the unc-47::GFP expressing neurons, with mod-1::mCherry expressed in both 
VD and DD classes of GABAergic motor neurons (Figure 3K). These motor neurons release 
GABA directly onto the body wall muscles to help generate body bends during locomotion (Von 
Stetina et al. 2006). We note that the mod-1 reporter is not expressed in all 26 GABAergic 
neurons – in the head the only overlap between the mod-1 and unc-47 reporter expression is in 
RME interneurons (Figure S1A). 
 In summary, the ser-4 reporter transgene expression was restricted to cells, including 
several types of head interneurons, that likely affect locomotion only indirectly. In contrast, the 
mod-1 expression pattern included the body wall muscles and GABAergic ventral cord neurons 
that directly control locomotion.  The only overlap in the mod-1 and ser-4 expression patterns 
appeared to be in the AIB head interneurons.  
 
MOD-1 and SER-4 serotonin receptors together mediate effects of optogenetically-released 
endogenous serotonin on locomotion 
MOD-1 and SER-4 are required for exogenous serotonin to paralyze C. elegans. Do MOD-1 and 
SER-4 have a normal physiological role in the control of locomotion by endogenously released 
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serotonin? We initially addressed this question by optogenetically stimulating neurotransmitter 
release from the serotonergic neurons of C. elegans and measuring whether MOD-1 and SER-4 
affect the resulting locomotion response. 
 Our optogenetic assays used a chromosomally-integrated transgene, ljIs102 (Ezcurra et 
al. 2011), to express the blue light-activated cation channel channelrhodopsin-2 (ChR2) fused to 
the yellow fluorescent protein YFP. A fragment of the promoter for the tph-1 gene (Sze et al. 
2000) was used to drive expression of ChR2::YFP specifically in serotonergic NSM and ADF 
neurons (Figure 4A). We performed all of our ChR2 assays in genetic backgrounds mutant for 
the C. elegans endogenous blue light receptor LITE-1 (Edwards et al. 2008), so that any 
locomotion responses to blue light should be entirely caused by ChR2 activation. 
 Upon stimulation by blue light to activate ChR2 and depolarize NSM and ADF, animals 
were nearly paralyzed (File S4). To quantitate this locomotion response, we counted the number 
of body bends during the first 30 seconds after turning on blue light illumination. To further 
ensure that the effects measured were caused by ChR2 activity, we assayed animals grown either 
in the presence or absence of all-trans retinal, a cofactor required for ChR2 activity. We found 
that ChR2 activation of NSM and ADF caused a 5.7-fold decrease in body bends (Figure 4B). 
This slowing of locomotion appeared to depend absolutely on release of serotonin, because it 
was absent in a mutant for bas-1, which encodes an enzyme required for serotonin and dopamine 
biosynthesis. We note that we were unable to use a tph-1 mutation in this experiment, which 
would block only serotonin and not dopamine biosynthesis, because the ChR2 transgene lies on 
chromosome II too close to the tph-1 gene to allow the necessary strain to be constructed. 
However, since the NSM and ADF neurons make serotonin and not dopamine, the bas-1 result 
strongly suggests that ChR2 stimulation caused slowing via release of serotonin. 
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 Our optogenetic assays showed that mod-1 and ser-4 together are required for the effects 
of endogenous serotonin on locomotion (Figure 4B). In the mod-1 or ser-4 mutant backgrounds, 
ChR2 activation caused only 1.8- or 3.1-fold decrease in body bends, respectively. In a genetic 
background mutant for both mod-1 and ser-4, ChR2 activation caused little if any reduction in 
body bends (p>0.05). 
 
MOD-1 and SER-4 serotonin receptors together mediate hyperenhanced slowing, an effect 
of endogenous serotonin on locomotion 
The optogenetic assay showed that MOD-1 and SER-4 can mediate effects of endogenously-
released serotonin on locomotion. For a more physiological assay of endogenous serotonin 
signaling, we analyzed how SER-4 and MOD-1 mutations affect a locomotion slowing behavior 
known to depend on natural release of endogenous serotonin. C. elegans slows when it 
encounters food in the form of a lawn of E. coli bacteria on an agar plate. If the animals are well 
fed, they show a modest “basal slowing” which depends on the release of the neurotransmitter 
dopamine (Sawin et al. 2000).  If the animals assayed are food-deprived for 30 minutes prior to 
being presented with food, they show a stronger “enhanced slowing” response, in which the 
additional slowing depends on release of serotonin from the NSM and other serotonergic neurons 
(Sawin et al. 2000). Finally, an even more dramatic “hyperenhanced slowing” response occurs in 
a null mutant for the serotonin reuptake transporter MOD-5: since MOD-5 activity terminates 
serotonin signaling, exaggerated responses to serotonin are seen in mod-5 mutants (Ranganathan 
et al. 2001). As shown in Figure 5B, food-deprived wild-type animals slowed their locomotion 
by about 75% when they encountered food, demonstrating enhanced slowing, while food-
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deprived mod-5 animals were almost completely paralyzed when they encountered food, 
demonstrating hyperenhanced slowing. 
 mod-1 was originally defined by Ranganathan et al. (2000) based on a mutant strain that 
was both serotonin-resistant and defective in the enhanced slowing response. Using the 
serotonin-resistant phenotype, these investigators mapped and cloned the mod-1 gene and found 
it to encode a serotonin-gated chloride channel. Subsequent work has indicated that mod-1 
mutants are not defective in the enhanced slowing response. First, the enhanced-slowing defect 
of the original mod-1 strain carrying the n3034 mutation proved to be conferred by a locus 
genetically separable from the mod-1 mutation as defined by the serotonin-resistant phenotype 
(D. Omura, personal communication). This observation indicated that the enhanced-slowing 
defect in this mod-1 strain was caused by a background mutation, now named n4954. Second, we 
have been unable to reproduce the enhanced-slowing defects reported by Ranganathan et al. 
(2000) for the mod-1(ok103) and mod-1(nr2043) strains. For example, Figure 5A shows our data 
for mod-1(ok103) animals. We do not know why the observations of Ranganathan et al. (2000) 
concerning the mod-1(ok103) and mod-1(nr2043) strains differ from our more recent 
observations. 
 We saw a very weak enhanced slowing defect for ser-4 (Figure 5A), and also at most a 
weak enhanced slowing defect in the mod-1; ser-4 double mutant (data not shown). To help 
understand if enhanced slowing response truly depends on serotonin, we measured enhanced 
slowing in a null allele for the serotonin biosynthesis gene tph-1, mutations in which were not 
available at the time of previously published studies of enhanced slowing (Figure 5A, right 
panel). In the absence of food, this tph-1 deletion mutant moved somewhat slowly than did the 
wild type. Despite this complication, the tph-1 mutant failed to slow in the presence of food to 
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the low rate of body bends seen in the wild type (p=0.002), and thus did show the expected 
enhanced slowing defect.  
 Since the hyperenhanced slowing response shows more dramatic effects of endogenous 
serotonin on locomotion than does the enhanced slowing response, we tested how ser-4 and 
mod-1 null mutations affected hyperenhanced slowing. Whereas food-deprived mod-5 single 
mutants were essentially paralyzed when they encountered food, two independent deletion alleles 
of mod-1 were significantly defective in this hyperenhanced slowing response (Figure 5B). The 
ser-4 deletion mutant was also defective in hyperenhanced slowing, and combining ser-4 and 
mod-1 deletions together produced yet a stronger defect (Figure 5C). Since we did not have a 
second independent deletion allele of ser-4, we used a ser-4 rescuing transgene to check if the 
effect of this deletion on enhanced slowing was indeed caused by the loss of ser-4 function. We 
found that the ser-4 transgene rescued the mod-5; ser-4; mod-1 triple mutant phenotype in the 
slowing assay to the phenotype of the mod-5; mod-1 double mutant. A mock ser-4 transgene, 
with a frameshift mutation in the ser-4 coding sequences, showed no such rescue (Figure 5C). 
 Our results show that MOD-1 and SER-4 together mediate hyperenhanced slowing, a 
behavioral effect of endogenous serotonin release. 
 
Discussion 
A genetic system for discovery and functional analysis of serotonin signaling proteins 
We developed large-scale genetic screens to isolate mutants with defects in serotonin response. 
Many past studies of serotonin signaling in C. elegans have analyzed gene knockouts for worm 
homologs of serotonin signaling proteins already known from studies in vertebrates. For 
example, mutants defective in enzymes required for serotonin biosynthesis and for serotonin 
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receptor homologs have revealed a number of behaviors that depend on serotonin (Sze et al. 
2000; Carnell et al. 2005; Dempsey et al. 2005; Hobson et al. 2006; Dernovici et al. 2007; 
Hapiak et al. 2009; Harris et al. 2009). However, the greatest potential for C. elegans genetics to 
illuminate mechanisms of serotonin signaling likely lies in genetic screens to discover new 
serotonin signaling proteins not previously known from vertebrate studies. 
 We chose locomotion as a serotonin-regulated behavior in C. elegans suitable for 
analysis by large-scale genetic screens. The simplest approach to such screens, applying 
serotonin to descendents of mutagenized animals and screening for animals that were not 
paralyzed, would have produced an overwhelming number of false positive isolates that did not 
carry serotonin-resistance mutations, because even high concentrations of serotonin do not 
paralyze 100% of wild-type animals.  We developed two alternative approaches:  clonal genetic 
screens and non-clonal screens using a mutation in the MOD-5 serotonin reuptake transporter in 
the genetic background. These approaches allowed us to screen animals representing 117,000 
mutagenized haploid genomes and to isolate 36 mutants resistant to the paralytic effects of 
exogenous serotonin. Although serotonin is used as a neurotransmitter in perhaps all organisms 
with a nervous system, to our knowledge no other large-scale systematic screens for mutants 
with serotonin signaling defects have been performed. 
 We developed new assays for measuring the effects of serotonin on locomotion to assess 
how specific mutations affect serotonin response. We discovered that C. elegans responds to 
exogenous serotonin at about 30-fold lower concentrations when it is dissolved in media lacking 
any salts instead of in the C. elegans media that have previously been used for serotonin 
response assays. This finding allowed us to perform more reliable assays in which serotonin was 
used at concentrations below its solubility limit. Even when applied in water, exogenous 
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serotonin must be presented at concentrations above 100 micromolar to affect wild-type C. 
elegans locomotion, raising concern that the responses seen might not be related to the 
physiological effects of endogenous serotonin. For this reason, we developed a new serotonin 
response assay based on channelrhodopsin2 stimulation of endogenous serotonin release. We 
also used hyperenhanced slowing behavior as a further assay of endogenous serotonin signaling. 
mod-1 and ser-4 mutations caused defects in all four assays we used: response to exogenous 
serotonin in high or low salt liquid, the optogenetic assay, and the hyperenhanced slowing assay. 
The strongest defects were seen when both receptors were mutated, and in some assays mutants 
lacking only a single receptor failed to show significant defects. Our results suggest mutations in 
other genes isolated based on defects for response to exogenous serotonin likely also affect 
endogenous serotonin signaling. However, any mutation that affects only one receptor signaling 
pathway might need to be combined with a second mutation affecting the other receptor 
signaling pathway to reveal effects on endogenous serotonin signaling.  
 
Eight proteins required for serotonin control of locomotion in C. elegans 
Our genetic screens identified eight genes required for serotonin response. Three of these genes 
encode the G protein coupled serotonin receptor SER-4, its potential target Gαo protein GOA-1, 
and the G protein regulator EAT-16 previously known to indirectly affect Gαo signaling (Hajdu-
Cronin et al. 1999). Two more genes encode the serotonin-gated chloride channel MOD-1 and 
the chloride transporter ABTS-1, previously known to control chloride channel function by 
affecting the chloride gradient across the plasma membrane (Bellemer et al. 2011).  
 How the remaining three proteins identified in our screens might affect serotonin 
response is less clear. EMB-9 is a basement membrane collagen (Graham et al. 1997). The NSM 
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neurosecretory neurons release serotonin directly onto a basement membrane surrounding the 
pharynx, so the serotonin must traverse the basement membrane to reach target cells outside the 
pharynx (Axäng et al. 2008). Perhaps exogenous serotonin also enters C. elegans through its 
pharynx by traversing this same basement membrane, and EMB-9 affects diffusion of serotonin 
through the basement membrane. 
 The flp-1 gene encodes several FMRFamide-related neuropeptides. Previous studies have 
shown that flp-1 mutations decrease the ability of exogenous serotonin to slow locomotion 
(Nelson et al. 1998) and that flp-1 appears to potentiate the ability of both endogenous and 
exogenous serotonin to stimulate egg-laying behavior (Waggoner et al. 1999). flp-1 is expressed 
in a subset of head interneurons (Nelson et al. 1998), but the mechanism by which FLP-1 
released from these cells directly or indirectly affects serotonin response in the locomotion and 
egg-laying systems of C. elegans remains to be determined. 
 The final protein identified by our genetic screens is ELPC-3, a subunit of a multisubunit 
complex known as elongator based on its initial discovery in yeast as a factor involved in 
transcriptional elongation (Otero et al. 1999). The ELPC-3 subunit has lysine acetylase activity 
and is highly evolutionarily conserved among all eukaryotes, with >65% identity among 
orthologs in various species from yeast to humans (Wittschieben et al. 1999). In animals, 
elongator is found in the nervous system, and mutations in the human elongator subunit Elp1 
cause the neurodegenerative disease familial dysautonomia (Slaugenhaupt and Gusella 2002). 
Elongator is found both in the nucleus and cytosol and has been shown to acetylate tubulin in C. 
elegans (Solinger et al. 2010). Elongator has not previously been implicated in serotonin 
signaling. However, a genome-wide association study found an association of a polymorphism 
upstream of the Elp3 gene with suicide ideation during treatment with an antidepressant that acts 
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as a selective serotonin reuptake inhibitor (Perroud et al. 2010). We suggest that elongator 
positively regulates serotonin signaling by acetylating and thus activating another protein that 
directly mediates serotonin signaling. Alternatively, elongator might very indirectly affect 
serotonin signaling since, for example, it is required for proper modification of tRNA in C. 
elegans (Chen et al., 2009) and might cause subtle defects in protein translation in neurons. 
 Our genetic screens have not yet reached a saturation scale. Nevertheless, as shown in 
Table 2, we recovered nine alleles of the Gαo gene goa-1, despite the fact that strong loss-of-
function goa-1 mutants are relatively sick and slow growing. The relatively high rate of isolating 
goa-1 mutants is likely because of their strong serotonin-resistance phenotype. Five genes were 
identified in our screens by only single alleles. Null mutants for these five genes are relatively 
healthy, show serotonin resistance similar to that seen in the screen isolates, and the genes are 
not particularly small, so there is no obvious reason why alleles for these genes should be rare. 
Of the 36 serotonin-resistant mutants we isolated, 17 have not yet been assigned to genes, and at 
least 11 of the 17 show a serotonin-resistance phenotype sufficiently strong to allow genetic 
mapping. We expect that further analysis of these mutants will identify additional serotonin 
signaling genes. 
 
Two receptors act in parallel to allow extrasynaptic serotonin to inhibit locomotion 
We have initiated analysis of the serotonin signaling proteins identified in our genetic screens 
with studies of the serotonin receptors. Because the other serotonin signaling proteins 
presumably affect signaling by one or more serotonin receptor, understanding how serotonin 
receptors control locomotion should provide the basis for assigning the remaining signaling 
proteins to the receptors they regulate or to which they respond. 
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 MOD-1 and SER-4 are the principal receptors that slow locomotion in response to 
exogenous serotonin and to the presumably high concentrations of endogenous serotonin 
released by optogenetic stimulation of the NSM and ADF neurons or in the hyperenhanced 
slowing assay. MOD-1 and SER-4 were the only serotonin receptors identified in our genetic 
screens for defects in response to exogenous serotonin, and knocking out both of these receptors 
together eliminated slowing in response to optogenetic release of endogenous serotonin (Figure 
4). The ser-4; mod-1 double knockout might also completely eliminate the serotonin-induced 
hyperenhanced slowing response: the residual slowing that occurs in the double knockout in this 
assay (Figure 5) might be entirely caused by the dopamine-induced basal slowing response. We 
note, however, that mod-1 and ser-4 knockouts had little or no effect on enhanced slowing, a 
more natural behavioral effect of presumably lower levels of endogenous serotonin. Further, 
application of high concentrations of exogenous serotonin caused residual slowing of ser-4; 
mod-1 double null mutants (Figure 2), again suggesting other serotonin receptors also contribute 
to the effects of serotonin on locomotion. Besides SER-4 and MOD-1, there are three other 
serotonin receptor homologs in C. elegans, and one report suggests that the SER-1 receptor has a 
significant effect on slowing in response to exogenous serotonin (Dernovici et al. 2007). 
However, another study did not find a strong effect of SER-1 (Hapiak et al. 2009), and we found 
that a ser-1 null mutation individually or in combination with mod-1 or ser-4 mutations had little 
effect in our assays for response to exogenous serotonin (data not shown). Thus existing assays 
show little effect of other serotonin receptors on locomotion compared to the strong effects of 
MOD-1 and SER-4. 
 Our genetic and expression-pattern studies suggest SER-4 and MOD-1 act independently 
of each other to slow locomotion. In one assay of response to exogenous serotonin and two 
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assays of response to endogenously-released serotonin, we found that ser-4; mod-1 double null 
mutants had more severe defects in serotonin response than did the single mutants lacking only 
one receptor. These results are consistent with the hypothesis that SER-4 and MOD-1 act 
independently and in parallel to mediate slowing in response to serotonin. In agreement with this 
hypothesis, ser-4 and mod-1 appear to be expressed in almost entirely non-overlapping sets of 
cells, with ser-4 expressed in many head interneurons, and mod-1 expressed in different 
interneurons as well as in the GABAergic motor neurons and body wall muscles that directly 
cause locomotion. Either SER-4 and MOD-1 act in parallel in these different cells, or they act in 
parallel in the only two cells in which they are coexpressed, the AIB interneurons, which 
synapses onto command interneurons and thus could mediate effects of serotonin on locomotion. 
The precise sites of action and mechanism by which the two receptors act to slow locomotion 
remain to be resolved. 
 Expression of the SER-4 and MOD-1 serotonin receptors does not appear to be limited to 
cells that receive synapses from serotonergic neurons. There are six pairs of neurons that contain 
serotonin, NSM, ADF, HSN, RIH, AIM, and VC4/5 (Sawin et al. 2000; Duerr et al. 2001; Jafari 
et al. 2011), and they form significant synapses onto 20 other types of neurons and onto the vm2 
egg-laying muscle cells (White et al. 1986). We found that the vm2 muscles express ser-4::GFP 
(Figure S1B). While we have not identified all of the neurons that express our ser-4 and mod-1 
reporters, the neurons we have identified do not correspond to any of the 20 neuron types 
postsynaptic to serotonergic neurons. For example, the GABAergic motor neurons of the ventral 
cord and the body wall muscles that express mod-1 do not receive synapses from serotonin 
neurons and are quite distant from any serotonin neurons. Thus, serotonin might diffuse from its 
release sites to act on distant cells. Consistent with this idea, previous work has shown that 
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serotonin from the NSM and ADF neurons travels extrasynaptically to the RIH and AIM 
neurons, which use the serotonin uptake transporter MOD-5 to accumulate serotonin (Jafari et al. 
2011). Furthermore, the neurons with by far the largest serotonin content in C. elegans are the 
NSM neurons, which are neurosecretory cells with no postsynaptic partners. The NSMs appear 
to be the principal neurons that release serotonin to cause slowing of locomotion (Sawin et al. 
2000). Studies of vertebrate brain are also consistent with the idea that serotonin diffuses and 
signals extrasynaptically (Bunin and Wightman 1998).  
 Our results lead to a model in which the NSM neurosecretory cells release serotonin 
extrasynaptically to diffuse across a basement membrane with an EMB-9 collagen component 
that facilitates diffusion across the membrane. The serotonin continues to diffuse to distant target 
cells and acts in parallel on different serotonin receptors, likely found on different cells. 
Signaling through the G protein coupled receptor SER-4 and its target G protein GOA-1, 
potentially in head interneurons, would provide one mechanism to slow locomotion. Signaling 
via the serotonin-gated chloride channel MOD-1, potentially on the GABAergic motor neurons 
and/or body wall muscles, would provide a second independent mechanism to slow locomotion. 
The remaining serotonin response proteins identified in our genetic screens could act to facilitate 
either the MOD-1 or SER-4 signaling pathways. It should be possible using the assays we 
describe to determine for each new C. elegans serotonin signaling protein which receptor 
pathway is affected. It would then be possible to determine if the mammalian homologs of these 
proteins play corresponding roles in serotonin signaling in the brain, and if deficits in any of 
these proteins are involved in human neuropsychiatric disorders, such as depression. 
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TABLE 1 ISOLATION AND CHARACTERIZATION OF SEROTONIN-RESISTANT MUTANTS 
 
Serotonin 
resistance 
mutationa 
Chrom-
osomeb 
Genetic 
back-
groundc 
Serotonin 
in screen 
(mM)d 
Mutagen Serotonin 
in assay 
(mM)e 
Percent moving 
in assayf 
None  wild type   30 4 
None  mod-5   5 4 
None  mod-5   15 1 
None  mod-5   30 0 
goa-1(vs115) I wild type 30 EMS 30 98 
goa-1(vs134) I wild type 30 EMS 30 74 
goa-1(n4093) I mod-5 20 Mos1 5 58 
goa-1(n4402) I mod-5 60 EMS 15 15 
goa-1(n4405) I mod-5 60 EMS 15 88 
goa-1(n4439) I mod-5 60 EMS 15 100 
goa-1(n4492) I mod-5 60 EMS 15 100 
goa-1(n4493) I mod-5 60 EMS 15 95 
goa-1(n4494) I mod-5 60 EMS 15 83 
eat-16(n4403) I mod-5 60 EMS 15 83 
abts-1(n4094) I mod-5 20 Mos1 5 90 
n3498 I mod-5 20 EMS 5 69 
n3792 I mod-5 20 EMS 5 43 
n4404 I mod-5 60 EMS 15 72 
n3461 II mod-5 20 EMS 5 86 
n3488 II mod-5 20 EMS 5 40 
n3495 II mod-5 20 EMS 5 35 
n3775 II mod-5 20 EMS 5 80 
ser-4(vs122) III wild type 30 EMS 30 66 
emb-9(vs114) III wild type 30 EMS 30 20 
flp-1(n4491) IV mod-5 60 EMS 15 83 
flp-1(n4495) IV mod-5 60 EMS 15 100 
mod-1(vs107) V wild type 30 EMS 30 61 
mod-1(n3791) V mod-5 20 EMS 30 100 
mod-1(n4054) V mod-5 20 Mos1 5 86 
n3510 V mod-5 20 EMS 30 45 
n3774 V mod-5 20 EMS 30 28 
n3799 V mod-5 20 EMS 10 34 
elpc-3(vs119) V wild type 30 EMS 30 70 
n3477 X mod-5 20 EMS 5 49 
vs113 unmapped wild type 30 EMS 30 12 
vs108 unmapped wild type 30 EMS 30 15 
vs111 unmapped wild type 30 EMS 30 16 
vs116 unmapped wild type 30 EMS 30 19 
vs120 unmapped wild type 30 EMS 30 20 
vs121 unmapped wild type 30 EMS 30 21 
a Allele designations without gene names are given for the 17 mutations not assigned to a gene. 
b The six weakest mutations (at bottom) have not been genetically mapped and thus are not assigned to a chromosome. 
c mod-5 denotes that the genetic screen and assays were performed in the mod-5(n3314) genetic background. 
d Concentration of serotonin in buffer used in the genetic screen that initially isolated the mutation. 
e Concentration of serotonin in M9 buffer at which mutant animals were assayed.  The strains at the top carried no serotonin 
resistance mutations and serve as controls. 
f Data averaged from 2-3 separate assays of 20-40 animals each.
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TABLE 2.  GENES IDENTIFIED BY SEROTONIN-RESISTANCE MUTATIONS 
Gene 
number of 
mutations 
isolated Protein encoded 
mod-1 3 serotonin-gated ion channel 
ser-4 1 G protein coupled serotonin receptor 
goa-1 9 neural G protein alpha subunit Gαo 
eat-16 1 regulator of G protein signaling 
abts-1 1 bicarbonate chloride exchanger 
flp-1 2 neuropeptide 
elpc-3 1 lysine acetyl transferase 
emb-9 1 basement membrane collagen 
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Figure Legends 
 
Figure 1 Schematic diagram of one of four genetic screens used to isolate serotonin-resistant 
mutants of C. elegans. Individual F1 progeny of mutagenized animals, each heterozygous for 
different mutations, were cultured in microtiter wells. Each F1 self-fertilized to produce a brood 
of F2 progeny. Serotonin (30 mM) was added to paralyze ~96% of animals in most wells (lower 
left). Rare wells (lower right) had ~25% F2 progeny that continued to move vigorously because 
they were homozygous for a mutation causing serotonin resistance. 
 
Figure 2 Effects of MOD-1 and SER-4 on the ability of serotonin to paralyze C. elegans in 
liquid. Young adult animals were placed in microtiter wells containing serotonin at the indicated 
concentrations and 20 minutes later were scored for movement. (A) Effects of ser-4 or mod-1 
deletion mutations on serotonin response when assayed in M9 buffer. (B) Effects of these 
mutations on serotonin response, alone or in combination, when assayed in water. (C) A MOD-1 
overexpressor transgene, mod-1(xs), produces serotonin hypersensitivity in a wild-type or ser-4 
mutant background.  Assays are in water as in panel B, but note the approximately 100-fold 
change in scale of the x-axis. Shown are the percents of animals paralyzed from samples of n=50 
(A) or n>100 (B, C) for each genotype and concentration, with error bars representing 95% 
confidence intervals. 
 
Figure 3 Expression patterns of mod-1 and ser-4 reporter transgenes are mostly distinct. Shown 
are confocal micrographs of transgenic animals in which the mod-1 promoter drives expression 
of the red fluorescent protein mCherry and the ser-4 promoter drives expression of green 
fluorescent protein (GFP). Red or green fluorescence and a merge of both superimposed on a 
brightfield image of the animal are shown, as indicated. (A-C) Adult head region. Arrow 
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indicates AIB, the only cell type that reliably coexpressed both reporters. Arrowhead indicates 
the serotonergic NSM neurons. The double-labeling pattern seen in panel (C) is shown in more 
detail in File S6, a movie of a rotating three-dimensional confocal image of the head region. (D-
F) Adult tail region. (G) mod-1:: mCherry fluorescence in an L3 larva superimposed on a 
brightfield image of the animal. Arrows point to mCherry-labeled ventral cord neurons (VNC), 
while brackets indicate labeled body wall muscles (bwm). (H) mod-1::mCherry expression in 
adult head. The white background used allows weak red fluorescence in body wall muscle to be 
visualized. Bracket indicates an individual muscle cell. (I-K) Lower magnification images of a 
young adult expressing mod-1::mCherry and an unc-47::GFP transgene that labels GABAergic 
neurons. Arrowheads in (K) point to the double-labeled GABA neurons of the ventral nerve cord 
that are most visible in this individual. Bars, 20 µm. 
 
Figure 4 SER-4 and MOD-1 receptors are required for control of locomotion by optogenetically 
released endogenous serotonin. (A) Image of the head region of an animal carrying the ljIs102 
transgene, which expresses ChR2::YFP in serotonergic neurons. A Nomarski optics image 
showing the anatomy of the head is superimposed on an image of yellow fluorescence. Labeled 
arrows point to YFP fluorescence in the NSM and ADF neurons.  Each neuron type is a 
bilaterally symmetric pair of cells, of which only the left member is visible in this micrograph. 
(B) Optogenetically-stimulated serotonin release slows locomotion dependent on the MOD-1 and 
SER-4 serotonin receptors. Young adults of the indicated genotypes grown either with or without 
the all-trans retinal cofactor required for ChR2 function were illuminated with blue light, and the 
number of body bends during the first 30 seconds of illumination was counted. In addition to the 
mutations indicated, all animals in this experiment carried a mutation in lite-1 (Edwards et al. 
2008) to block the endogenous response to blue light of C. elegans. Asterisks indicate significant 
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slowing (p<0.05, one-tailed t-test) in all-trans retinal-treated animals relative to the controls 
without all-trans retinal. 
 
Figure 5 Effects of SER-4 and MOD-1 receptors on enhanced and hyperenhanced slowing,  
behavioral responses dependent on endogenous serotonin. (A) Enhanced slowing was measured 
by first food-depriving young adults for 30 minutes, transferring the animals to agar plates with 
our without food (a lawn of bacteria), and scoring locomotion by measuring the rate of body 
bends. mod-1(ok103) (shown) had no significant defect (p=0.76, Student’s t-test), and two other 
mod-1 alelles gave similar results (data not shown). The ser-4 deletion mutation caused a modest 
but significant (p=0.01) defect in enhanced slowing. As a positive control, the serotonin-deficient 
mutant tph-1(n4622) was assayed and failed to slow as much as did the wild type (p=0.02). (B, 
C) Hyperenhanced slowing was measured by using the same assay on animals carrying 
mutations in the MOD-5 serotonin reuptake transporter (B) Upon exposure to food, wild-type 
animals slowed, while mod-5 mutants demonstrated hyperenhanced slowing by almost 
completely stopping all body bends. Two independent mod-1 deletion mutants were partially 
defective for hyperenhanced slowing. (C) The ser-4 deletion mutation caused defective 
hyperenhanced slowing and added to the defect of the mod-1(ok103) mutant. This additional 
defect was rescued by a ser-4 transgene but not by a mock ser-4 transgene containing a frame-
shift mutation that blocks SER-4 expression. Brackets with asterisks indicate significant 
differences (p<0.05, Student's t-test). ns, not significant. 
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Supporting Information 
 
TABLE S1:  MOLECULAR LESIONS OF MUTATIONS IDENTIFIED IN THIS WORK 
 
Serotonin 
resistance 
mutation 
Nucleotide sequence of the 
wild typea 
Nucleotide sequence of the 
mutanta 
Affected 
amino 
acid in 
the wild-
type 
protein 
Amino acid 
in the 
mutant 
protein 
goa-1(vs115) tgcgtatattCaagcacaatt tgcgtatattTaagcacaatt Q305 Stop 
goa-1(vs134) agacggcatgCaagcggcaaa agacggcatgTaagcggcaaa Q29 Stop 
goa-1(n4093) tgcaccacatacagtgagtca tgcaccacat[Mos1]acagt
gagtca 
  
goa-1(n4402) cttcgtggatGcggcttgtat cttcgtggatAcggcttgtat C351 Y 
goa-1(n4405) ctagcgccatGggttgtacca ctagcgccatAggttgtacca M1 N/A 
goa-1(n4439) catattttcaGaaccgaatgc catattttcaAaaccgaatgc intron 5 
splice 
acceptor  
N/A 
goa-1(n4492) ttttcagaacCgaatgcacga ttttcagaacTgaatgcacga R243 Stop 
goa-1(n4493) aacggttgtgGggagacgcag aacggttgtgAggagacgcag W132 Stop 
goa-1(n4494) agcgaataagGtaagaaaaaa agcgaataagAtaagaaaaaa intron 7 
splice 
donor 
N/A 
eat-16(n4403) aaccctcgatCagacattgga aaccctcgatTagacattgga   
abts-1(n4094) actttcatcgattatacagct actttcatcga[Mos1]ttat
acagct 
N/A N/A 
ser-4(vs122) atttttgcagGttacctaaac atttttgcagAttacctaaac G410 D 
emb-9(vs114) ggtcagccagGttatccagga ggtcagccagAttatccagga G1197 D 
flp-1(n4491) ttattattcaGgtgtcggcag ttattattcaAgtgtcggcag intron 1 
splice 
acceptor 
N/A 
flp-1(n4495) atcattttcaGgtcgaagtga atcattttcaAgtcgaagtga intron 4 
splice 
acceptor 
N/A 
mod-1(vs107) atggatgtgtGgatgcttgga atggatgtgtAgatgcttgga W305 Stop 
mod-1(n3791) ttgtatcttgGgtttcattct ttgtatcttgAgtttcattct W258 Stop 
mod-1(n4054) ctacgtcttactttccagttt ctacgtcttac[Mos1]tttc
cagttt 
N/A N/A 
elpc-3(vs119) catgtatacgGatccgtcgtt catgtatacgAatccgtcgtt G475 E 
a The affected nucleotide is capitalized and 10 nucleotides on either side are shown. 
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Supplemental Figure Legends 
 
Figure S1 Further details of mod-1 and ser-4 reporter expression patterns. (A) Adult head region 
showing mod-1::mCherry and unc-47::GFP fluorescence superimposed on a brightfield image of 
the animal. The unc-47 reporter labels GABAergic neurons. This image demonstrates that not all 
GABAergic neurons expressed mod-1::mCherry. The two doubled-labeled GABAergic cells 
(arrow) that did express mod-1::mCherry were RME interneurons. (B) Ventral view of the vulval 
region of a young adult expressing ser-4::GFP. Arrows, the fluorescent ventral nerve cord 
(VNC) running the length of the animal. Arrowheads, the four vm2 muscle cells also labeled by 
ser-4::GFP.  Bar=40 µm. 
 
File S1 A 30-second video clip showing wild-type animals in a microtiter well containing 50 µl 
of water and no serotonin. These animals were all scored as “moving,” in that they showed the 
continuous full-body thrashing movements. 
 
File S2 A 30-second video showing wild-type animals in a microtiter well containing 50 µl water 
with a serotonin concentration (5 mM) sufficient to fully paralyze the animals, prepared as for 
the assays shown in Figure 2B. These animals were all scored as not “moving,” in that they did 
not show the continuous full-body thrashing movements. One animal briefly made body bends 
halfway through the video. 
 
File S3 Three-dimensional rotation of the head region of a double-transgenic animal carrying the 
mod-1::mCherry and ser-4::GFP transgenes showing a merge of the red and green fluorescence.  
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The bilaterally symmetric double-labeled neurons visualized in yellow are the left and right AIB 
neurons.  
 
File S4 Two 15-second videos showing slowing of locomotion during optogenetic stimulation of 
serotonin release.  Animals shown carried the ljIs102 transgene, which expresses ChR2::YFP in 
the NSM and ADF serotonergic neurons, as well as a mutation in lite-1, to block the endogenous 
blue light response of C. elegans.  Animals are shown prior to, during, and after a several second 
illumination with blue light. 
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Extended Materials and Methods 
 
C. elegans strains 
The wild-type strain was Bristol N2.  Additional C. elegans strains used in this work are listed 
below, followed by a table listing the transgenes shown within the genotypes and a description of 
the plasmids used to generate the transgenes. 
 
Figure 2: N2, AQ866 ser-4(ok512) III, MT9668 mod-1(ok103) V, LX1834 ser-4(ok512) III; 
mod-1(ok103) V, LX1166 lin-15(n765ts) X; vsIs123, LX1835 ser-4(ok512) III; lin-
15(n765ts) X; vsIs123 
 
Figure 3: LX1851 lin-15(n765ts) vsIs163 X, LX1858 lin-15(n765ts) X; vsIs154; ljIs570,  
LX1857 oxIs12 lin-15(n765ts) X; vsIs163      
 
Figure 4: AQ2050 lite-1(ce314) X; ljIs102, LX1841 bas-1(ad446) III; lite-1(ce314) X; ljIs102, 
LX1838 mod-1(ok103) V; lite-1(ce314) X; ljIs102, LX1839 ser-4(ok512) III; lite-
1(ce314) X; ljIs102, LX1842 ser-4(ok512) III; mod-1(ok103); lite-1(ce314) X; ljIs102 
 
Figure 5: N2, MT9668 mod-1(ok103) V, MT9667 mod-1(nr2043) V, MT9772 mod-5(n3314) I, 
MT14121 mod-5(n3314) I; ser-4(ok512) III, MT9849 mod-5(n3314) I; mod-1(ok103) V, 
MT10143 mod-5(n3314) I; mod-1(nr2043) V, MT14126 mod-5(n3314) I; ser-4(ok512) 
III; mod-1(ok103) V, MT17972 mod-5(n3314) I; ser-4(ok512) III; mod-1(ok103) V; 
   45 
nEx1403, MT17973 mod-5(n3314) I; ser-4(ok512) III; mod-1(ok103) V; nEx1404, 
MT14984 tph-1(n4622) II 
 
Figure S1:  LX1857 oxIs12 lin-15(n765ts) X; vsIs163, LX1858 lin-15(n765ts) X; vsIs154; 
ljIs570 
 
File S1:  N2 
 
File S2:  N2 
 
File S3:  LX1858 lin-15(n765ts) X; vsIs154; ljIs570 
 
File S4:  AQ2050 lite-1(ce314) X; ljIs102 
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Table S2 C. ELEGANS TRANSGENES USED IN THIS WORK 
 
 
Trans-
gene 
Purpose Used in  Source 
vsIs123 Overexpression of MOD-1. Carries multiple copies of 
wild-type mod-1 genomic 
DNA. 
Figure 2 This work.  Microinjection of a mod-1 
long-range PCR product at 20 ng/µl and 
pL15EK (a lin-15 rescuing plasmid used 
as a coinjection marker) at 50 ng/µl 
Chromosomal integration via 
UV/psoralen mutagenesis 
 
vsIs154 
vsIs163 
Expression of mCherry 
from the mod-1 promoter. 
These two alleles are 
independent chromosomal 
integrants. 
Figures 
3, S1, 
File S3 
This work. Microinjection of the mod-
1::mCherry plasmid pGG17 at 65 ng/µl 
and pL15EK at 50 ng/µl 
Chromosomal integration via 
UV/psoralen mutagenesis 
 
oxIs12 Expression of GFP in 
GABAergic neurons from 
the unc-47 promoter. 
Figures 
3, S1 
McIntire et al. 1997 
ljIs102 Expression of 
Channelrhodopsin2::YFP 
in the serotonergic NSM 
and ADF neurons . 
Figure 4 
File S4 
Ezcurra et al. 2011 
nEx1403 Rescue of the ser-4 mutant 
phenotype by expression of 
a ser-4 cDNA from the ser-
4 promoter. 
Figure 5 This work. Microinjection of the plasmid 
pMG12 at 10 ng/µl and pL15EK at 20 
ng/µl 
nEx1404 Negative control for ser-4 
rescue.  Similar to nEx1403 
except that the ser-4 cDNA 
used carries a frame shift 
mutation that prevents 
expression of SER-4 
protein. 
Figure 5 This work. Microinjection of the plasmid pMG13 at 10 ng/µl and pL15EK at 20 
ng/µl 
ljIs570  Expression of GFP from 
the ser-4 promoter. 
Figure 3 
File S3 
A gift of S. Shyn and W. Schafer. 
Chromosomal integrant of the 
extrachromosomal transgene adEx1616 
from Tsalik et al. (2003) 
vsIs48 Expression of GFP in 
cholinergic neurons from 
the unc-17 promoter. 
Data not 
shown 
Chase et al. 2004 
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Construction of transgenes 
 The ser-4::GFP reporter transgene adEx1616 developed by Tsalik et al. (2003) was used 
to produce the chromosomally-integrated transgene ljIs570 by S. Shyn and W. Schafer and 
kindly provided to us for these studies. The mod-1::mCherry reporter plasmid pGG17 was 
constructed by inserting a 1645 bp mod-1 promoter fragment upstream and the 1172 bp 3’ 
untranslated region (UTR) of mod-1 downstream of the mCherry coding sequences to generate 
plasmid pGG17. The primers used to amplify the promoter were 
GACTCTGCAGGCGTTCGTCACATTCTGCCG and 
CTGAGGTACCAATTTTCTTTCACCGCATTGGC. The primers used to amplify the 3’ UTR 
were GACTGAGCTCTTGAAGTTTATCCCTT and 
GACTGGGCCCTAATCACAGGTGTCATCGG. Injection of pGG17 into C. elegans gave 
transgenes showing very weak mCherry expression, but following the method of Etchberger and 
Hobert (2008) we found that PCR amplification of the promoter::mCherry::3’ UTR cassette from 
the plasmid and injection of the linear amplified DNA gave much stronger expression. An 
extrachromosomal transgene generated in this manner was chromosomally integrated using 
psoralen/UV mutagenesis to produce two independent integrated transgenes, vsIs154 and 
vsIs163. For double labeling, animals carrying these mCherry transgenes were crossed with 
animals carrying the unc-47::GFP transgene osIx12 (McIntire et al. 1997), which labels 
GABAergic neurons or the unc-17::GFP transgene vsIs48 (Chase et al. 2004), which labels 
cholinergic neurons. 
 The mod-1 overexpressing transgene vsIs123 was generated by directly microinjecting a 
long-range PCR product containing the entire mod-1 gene into a lin-15(n765ts) strain of C. 
elegans at 20 ng/µl with the lin-15 rescuing plasmid pL15EK at 50 ng/µl, selecting non-Lin 
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progeny, and subsequently using psoralen/UV mutagenesis to chromosomally integrate the 
transgene. The mod-1 PCR product was amplified from C. elegans genomic DNA using the 
primers CTAATCACAGGTGTCATCGG and GCGTTCGTCACATTCTGCCG.  
 The ser-4 rescuing plasmid pMG12 contained a 5 kb fragment of the ser-4 promoter 
region followed by a ser-4 cDNA and the 3' untranslated region from the unc-54 gene. The ser-4 
promoter fragment was PCR amplified using the primers 
GCGCGCATGCCAGAGGAGTTCGCCACACAACACGTCAC and 
GCGCGCATGCGTGGAGTTGCACACAACACCGGAAGC containing the restriction sites 
SphI and BamHI, respectively. We amplified the ser-4 cDNA yk1731h09 (kindly provided by Y. 
Kohara) using the primers GCGCGGTACCATGATCGACGAGACGCTTCJTCAATC and 
GCGCGATATCACTAGTCTAGCGGCCGCGACCTGCAGC containing the restriction sites 
KpnI and EcoRV, respectively. These restriction sites were used to ligate the two fragments into 
the vector pPD49.25 (kindly provided by A. Fire), which supplied the unc-54 3' untranslated 
region. A negative control plasmid, pMG13, was identical to pMG12 but carried a frameshift 
mutation in the ser-4 cDNA: we inserted two G residues after nucleotide 91 of ser-4 exon 1.  The 
transgenes nEx1403 and nEx1404 were generated by microinjecting pMG12 or pMG13, 
respectively, at 10 ng/µl, along with the lin-15 rescuing plasmid pL15EK at 20 ng/µl, into a ser-
4(ok512); lin-15(n765ts) strain and selecting non-Lin progeny. 
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